Home » Newsletters » BioWorld

BioWorld

Nov. 8, 1993

View Archived Issues

TELIOS FILES IND ON ANTI-THROMBOTIC

China Approves Ecogen Bioinsecticides

COMPASSIONATE USE PROGRAM FOR AIDS DRUG

CTI FILES IND FOR SEPTIC SHOCK DRUG

REGENERON CO-DEVELOPING NEW NEURO-MOLECULE

UBI BEGINS HIV VACCINE TRIALS

AIDS VACCINE CONFERENCE

FINAL TALLY FROM CORTECH'S OFFERING IS $38M

DETAILS OF CENTOCOR'S PACT WITH WELLCOME

COBE INVESTS $20M IN AASTROM FOR STEM CELL THERAPY

RESEARCHERS DISCOVER THE T CELL ACTIVATION SWITCH

MONSANTO'S BST CLEARS FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...